Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational Study.
- Author:
Kwangsung PARK
1
;
Hyoung Keun PARK
;
Sae Woong KIM
;
Dae Yul YANG
;
Jong Kwan PARK
;
Hyun Jun PARK
;
Ki Hak MOON
;
Du Geon MOON
;
Kweon Sik MIN
;
Hwancheol SON
;
Sung Won LEE
;
Jae Seog HYUN
;
Woo Suk CHOI
;
Sang Kuk YANG
Author Information
- Publication Type:Multicenter Study ; Original Article
- Keywords: Lower urinary tract symptoms; Nocturia; Prostatic hyperplasia; Therapeutics
- MeSH: Humans; Lower Urinary Tract Symptoms; Male; Nocturia*; Observational Study*; Prospective Studies*; Prostate; Prostatic Hyperplasia
- From:The World Journal of Men's Health 2018;36(3):248-254
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study was to evaluate the efficacy of treatment in patients with non-bothering nocturia. MATERIALS AND METHODS: In this prospective multicenter study, patients who visited hospitals for treatment of voiding symptoms were enrolled. Inclusion criteria were: 1) men >45 years, and 2) nocturia ≥2 confirmed by a three-day voiding diary. Subjects were divided into non-bothering and bothering groups based on International Consultation on Incontinence Questionnaire Nocturia (ICIQ-N) question 2b. Changes in voiding symptoms, frequency of nocturia, and bothersomeness were evaluated with international prostate symptom score (IPSS), ICIQ-N, and three-day voiding diary at 4 and 12 weeks after treatment. RESULTS: A total of 48 patients in the non-bothering nocturia group and 50 patients in the bothering nocturia group who completed the 12-week treatment were analyzed. The total IPSS was decreased by 5.8 in the non-bothering group and 5.2 in the bothering group. There was no significant difference in decrease of IPSS between the two groups. Both groups showed significant reduction in discomfort of nocturia. The ICIQ-N 2b score decreased from 3.9 to 2.7 (p=0.01) in the non-bothering group and from 6.9 to 4.6 (p=0.02) in the bothering group. The number of nocturia episodes was significantly decreased in both groups. CONCLUSIONS: Regardless of discomfort associated with nocturia, both groups showed significant improvement in nocturia-related discomfort and voiding symptoms. These results suggest that patients with nocturia who were unaware of its discomfort benefited from treatment.
